NASDAQ: BRTXBiorestorative Therapies Inc Stock Ownership - Who owns Biorestorative Therapies?
Insider buying vs selling
Have Biorestorative Therapies Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Lance Alstodt | President CEO COB | 2025-10-06 | 15,625 | $1.60 | $25.00kBuy |
| Francisco Silva | VP of Research and Development | 2025-10-06 | 11,719 | $1.60 | $18.75kBuy |
BRTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BRTX insiders and whales buy or sell their stock.
BRTX Shareholders
What type of owners hold Biorestorative Therapies Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Westbury Bermuda Ltd | 258.06% | 65,750,000 | $13.81M | Insider |
| Trust Westbury | 74.77% | 19,049,578 | $4.00M | Insider |
| Antonio Joel San | 49.06% | 12,500,000 | $2.63M | Insider |
| Janet Montgomery | 7.28% | 1,854,428 | $389.43k | Insider |
| Dale Broadrick | 7.04% | 1,793,808 | $376.70k | Insider |
| John M. Desmarais | 1.94% | 493,398 | $103.61k | Insider |
| Citadel Advisors LLC | 0.94% | 238,606 | $50.11k | Institution |
| Geode Capital Management LLC | 0.88% | 223,083 | $46.85k | Institution |
| Joseph B. Swiader | 0.75% | 191,267 | $40.17k | Insider |
| Lance Alstodt | 0.74% | 187,497 | $39.37k | Insider |
BRTX vs Biotech Stocks
Biorestorative Therapies Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.